Derivation and validation of an equation for adjustment of neuron-specific enolase concentrations in hemolyzed serum

被引:20
作者
Berger, Rachel [1 ]
Richichi, Rudolph [2 ]
机构
[1] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA
[2] Stat Anal & Measurement Consultants, Lanexa, VA USA
基金
美国国家卫生研究院;
关键词
neuron-specific enolase; hemolysis; brain injury; children; derivation and validation; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; MARKERS; PROTEINS; DAMAGE; NSE;
D O I
10.1097/PCC.0b013e31819a376d
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To derive and validate a formula to allow for adjustment of serum neuron-specific enolase (NSE) concentrations based on the amount of hemolysis in the sample. To compare the accuracy of qualitative and quantitative assessment of hemolysis. Design: Derivation and validation of a formula. Subjects: Eighty-three children <11 years of age were used for the derivation. Twenty-three children <11 years without brain injury and 30 with brain injury were used for the validation. Interventions: We evaluated the amount of hemolysis quantitatively using a hemocue and qualitatively by visualization. We measured NSE concentrations by enzyme-linked immunosorbent assay. Using a subset of subjects, we used linear regression analysis to derive an equation to adjust serum NSE concentrations based on the degree of hemolysis. We prospectively validated the formula in a different group. NSE <= 11.5 ng/mL was considered normal. Results: The formula derived was as follow: Adjusted NSE = Unadjusted NSE - (1.659) (square root of the hemocue). In the validation, 96% of children without brain injury had a normal adjusted NSE; 93% of children with brain injury had an abnormal adjusted NSE. Qualitative analysis of hemolysis was inconsistent and both overassessed and under-assessed hemolysis as quantified by hemocue. Conclusions: We retrospectively derived and prospectively validated an equation for adjusting serum NSE concentrations based on the amount of hemolysis in the sample. Use of this formula will allow for accurate measurement of NSE even in hemolyzed sample and may improve its usefulness as a marker of brain injury in children. Qualitative assessment of the degree of hemolysis is not accurate and should not be used. (Pediatr Crit Care Med 2009; 10:260-263)
引用
收藏
页码:260 / 263
页数:4
相关论文
共 16 条
  • [1] Akhtar Javed I, 2003, Pediatr Crit Care Med, V4, P322
  • [2] Brain-specific NSE and S-100 proteins in umbilical blood after normal delivery
    Amer-Wåhlin, I
    Herbst, A
    Lindoff, C
    Thorngren-Jerneck, K
    Marsál, K
    Alling, C
    [J]. CLINICA CHIMICA ACTA, 2001, 304 (1-2) : 57 - 63
  • [3] Identification of inflicted traumatic brain injury in well-appearing infants using serum and cerebrospinal markers: A possible screening tool
    Berger, RP
    Dulani, T
    Adelson, PD
    Leventhal, JM
    Richichi, R
    Kochanek, PM
    [J]. PEDIATRICS, 2006, 117 (02) : 325 - 332
  • [4] Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children
    Berger, RP
    Adelson, PD
    Pierce, MC
    Dulani, T
    Cassidy, LD
    Kochanek, PM
    [J]. JOURNAL OF NEUROSURGERY, 2005, 103 (01) : 61 - 68
  • [5] Hemolysis in serum samples drawn by emergency department personnel versus laboratory phlebotomists
    Burns, ER
    Yoshikawa, N
    [J]. LABORATORY MEDICINE, 2002, 33 (05) : 378 - 380
  • [6] S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients - A comparison with healthy controls
    de Kruijk, JR
    Leffers, P
    Menheere, PPCA
    Meerhoff, S
    Twijnstra, A
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2001, 103 (03): : 175 - 179
  • [7] Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography
    Herrmann, M
    Jost, S
    Kutz, S
    Ebert, AD
    Kratz, T
    Wunderlich, MT
    Synowitz, H
    [J]. JOURNAL OF NEUROTRAUMA, 2000, 17 (02) : 113 - 122
  • [8] Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171
  • [9] Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003
  • [10] Lemery L., 1998, ADV MED LAB PROFESSI, V2, P24